NCT01241734 2026-04-08
RICER
Hackensack Meridian Health
Phase 1/2 Completed
Hackensack Meridian Health
Novartis
Otsuka Pharmaceutical Co., Ltd.
Chipscreen Biosciences, Ltd.
Calibr, a division of Scripps Research
University College, London
Canadian Cancer Trials Group